Breaking News

BioCorRx Forms Subsidiary

New company will focus on development and commercialization activities of the technology for an injectable naltrexone

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

BioCorRx, developer of the BioCorRx Recovery Program, a medication-assisted treatment (MAT) program, has formed a new subsidiary, BioCorRx Pharmaceuticals, in conjunction with the company’s development, commercialization and license agreement with TheraKine for exclusive worldwide rights, licenses and sublicensing to patented and patent pending TheraKine technology for sustained release naltrexone delivery. BioCorRx Pharmaceuticals will focus on development and commercialization activit...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters